Neidig Brent sold $50K of USNA
Neidig Brent (CHIEF COMMERCIAL OFFICER) sold 2,511 shares of USANA HEALTH SCIENCES INC (USNA) at an average of $20.10 ($20.00–$20.15) across 2 trades over 2026-06-12 to 2026-06-15.
How this was made
The 30-second read
Why it matters
This provides a fresh, primary-source datapoint on insider activity, but it does not include earnings, guidance, litigation, or operational changes.
Market read
Traders may note insider selling, but the disclosed dollar value is small and lacks accompanying fundamental catalysts.
What to watch
Insider sales can be driven by diversification, tax, or pre-planned personal liquidity needs; without additional context, the trading signal is weak.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for USANA Health Sciences Inc.
Ticker impact
USANA’s chief commercial officer filed a Form 4 selling 2,511 shares in open-market transactions at about $20.10/share.
Near-term impact likely minimal; any reaction would be small and quickly mean-reverting unless paired with other news.
The filing is an officer open-market sale with no 10b5-1 plan stated, but the disclosed size ($50.5k) is small and not a corporate action or guidance change.
Market effects
No sector-level read-through; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
The absence of a stated 10b5-1 plan could be viewed as less “scheduled,” but the transaction size is still too small to be a strong fundamental signal.
Key entities
- issuerUSANA Health Sciences Inc
Company whose officer insider sale is disclosed on Form 4.
- insiderNeidig Brent
Chief Commercial Officer who sold 2,511 shares in open-market transactions.
